Alimera Sciences Net debt/EBITDA
Quel est le Net debt/EBITDA de Alimera Sciences?
Le Net debt/EBITDA de Alimera Sciences Inc. est -46.51
Quelle est la définition de Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA des entreprises dans Health Care secteur sur NASDAQ par rapport à Alimera Sciences
Que fait Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Entreprises avec net debt/ebitda similaire à Alimera Sciences
- Inca One Gold a Net debt/EBITDA de -47.04
- Journeo plc a Net debt/EBITDA de -46.99
- McBride Plc a Net debt/EBITDA de -46.99
- Raise Production a Net debt/EBITDA de -46.96
- Summer Infant Inc a Net debt/EBITDA de -46.90
- Majestic Wine Plc a Net debt/EBITDA de -46.57
- Alimera Sciences a Net debt/EBITDA de -46.51
- Husky a Net debt/EBITDA de -46.47
- Hydoo International a Net debt/EBITDA de -46.45
- Partner Jet a Net debt/EBITDA de -46.32
- China Wan Tong Yuan () a Net debt/EBITDA de -46.19
- Trafalgar Property plc a Net debt/EBITDA de -46.15
- Astronics a Net debt/EBITDA de -46.11